Aspira Pathlab Approves Rights Issue to Raise Up to Rs 65 Crore
Aspira Pathlab & Diagnostics Ltd 路 Outcome 路 12 Sept 2026, 10:18 pm
Aspira Pathlab Approves Rights Issue to Raise Up to Rs 65 Crore Aspira Pathlab & Diagnostics' Board approved a fundraise of up to Rs 65 crore via a Rights Issue of equity shares or other convertible instruments on 12th Sep'26, subject to shareholder and regulatory approvals. The Board constituted a Rights Issue Committee, chaired by Nikunj Velji Mange, to finalize issue terms, including the record date, issue price, and rights entitlement ratio.
Original exchange filing (PDF)
More announcements from Aspira Pathlab & Diagnostics Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 18 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 14 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 14 Nov 2026
- Enclosed herewith Financial Result for the Half Year ended 30th September 2026 路 06 Nov 2026
- Enclosed herewith Board Meeting Outcomes dated 6th November 2026 路 06 Nov 2026
- Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Un-audited Financial .... 路 06 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 01 Oct 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 28 Sept 2026
